E-LIB Suche - Ergebnisse für: McArthur, Grant A.

1

POLARIS: A phase 2 trial of encorafenib plus binimetinib ev..:

Menzies, Alexander M ; Long, Georgina V ; Kohn, Amiee...
Neuro-Oncology Advances. 6 (2024) 1 - p. , 2024

Link: https://doi.org/10.1093/..

2

The side effect registry immuno-oncology (SERIO) – A tool f..:

Ertl, Carolin ; Ruf, Theresa ; Mentzer, Dirk...
European Journal of Cancer. 199 (2024) - p. 113505 , 2024

Link: https://doi.org/10.1016/..

3

Statin use in resected, high-risk cutaneous melanoma: A mul..:

Wang, Charlie Yue ; Shackleton, Mark ; Mailer, Sonia...
EJC Skin Cancer. 2 (2024) - p. 100017 , 2024

Link: https://doi.org/10.1016/..

4

Designing a wholly online, multidisciplinary Master of Canc..:

Lai-Kwon, Julia ; Dushyanthen, Sathana ; Seignior, David...
BMC Medical Education. 23 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

5

Overall survival with first-line atezolizumab in combinatio..:

Ascierto, Paolo A ; Stroyakovskiy, Daniil ; Gogas, Helen...
The Lancet Oncology. 24 (2023) 1 - p. 33-44 , 2023

Link: https://doi.org/10.1016/..

6

The therapeutic potential of targeting minimal residual dis..:

Patel, Riyaben P ; Somasundram, Pretashini M ; Smith, Lorey K...
Clinical and Translational Medicine. 13 (2023) 3 - p. , 2023

Link: https://doi.org/10.1002/..

7

Efficacy and toxicity of adjuvant radiotherapy in recurrent..:

Bhave, Prachi ; Hong, Angela ; Lo, Serigne N...
Journal for ImmunoTherapy of Cancer. 11 (2023) 3 - p. e006629 , 2023

Link: https://doi.org/10.1136/..

8

Validation of epidermal AMBRA1 and loricrin (AMBLor) as a p..:

Ewen, Tom ; Husain, Akhtar ; Stefanos, Niki...
British Journal of Dermatology. 190 (2023) 4 - p. 549-558 , 2023

Link: https://doi.org/10.1093/..

9

A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in..:

Tan, Lavinia ; Tran, Ben ; Tie, Jeanne...
Clinical Cancer Research. 29 (2023) 6 - p. 1017-1030 , 2023

Link: https://doi.org/10.1158/..

10

Prospective comparison of volumetric post-contrast T1-Sampl..:

Lasocki, Arian ; Caspersz, Lauren ; McArthur, Grant A
The Neuroradiology Journal. 36 (2022) 2 - p. 169-175 , 2022

Link: https://doi.org/10.1177/..

11

First-In-Human Phase I Study of the OX40 Agonist MOXR0916 i..:

Kim, Tae Won ; Burris III, Howard A. ; de Miguel Luken, Maria J....
Clinical Cancer Research. 28 (2022) 16 - p. 3452-3463 , 2022

Link: https://doi.org/10.1158/..

12

BRAF mutation testing for patients diagnosed with stage III..:

Scolyer, Richard A. ; Atkinson, Victoria ; Gyorki, David E....
Pathology. 54 (2022) 1 - p. 6-19 , 2022

Link: https://doi.org/10.1016/..

13

Characterization of the treatment-naive immune microenviron..:

Wang, Minyu ; Zadeh, Soroor ; Pizzolla, Angela...
Journal for ImmunoTherapy of Cancer. 10 (2022) 4 - p. e004095 , 2022

Link: https://doi.org/10.1136/..

14

Harnessing the immunotherapeutic potential of CDK4/6 inhibi..:

Lelliott, Emily J. ; Sheppard, Karen E. ; McArthur, Grant A.
npj Precision Oncology. 6 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

15

Adaptive translational reprogramming of metabolism limits t..:

Smith, Lorey K. ; Parmenter, Tiffany ; Kleinschmidt, Margarete...
Nature Communications. 13 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..